WoundScribe AI
Share
X Facebook WhatsApp Email

Pay-per-Chart Pricing FAQ: Credits, Seats, and Wound Care EMR Billing

pricing

Published

Straight answers on how Pay-per-Chart credits work, what happens if a draft is wrong, and how billing compares to per-seat wound care EMR contracts.

Practices evaluating a credit-based EMR ask the same questions in the same order. Here are the answers.

Are credits per user or per practice?

Per practice. One shared pool covers every clinician, nurse, and MA on the account. Add or remove staff without touching pricing.

When exactly is a credit spent?

Only when the AI drafts a chart. Logging in, viewing a patient record, uploading a photo, or reviewing a past note costs nothing. The credit is consumed when the six-agent pipeline produces a SOAP note for a wound visit.

What if the draft is wrong or the visit didn't happen?

If a draft fails to generate or a visit is voided before signoff, the credit is not consumed. You approve what's usable — you don't pay for garbage.

Do credits expire?

No monthly burn-down. Buy what your caseload needs and top up when the pool runs low. Slow weeks don't waste spend.

Is there a minimum team size or contract length?

No. Account creation and the AI-powered EMR for wound care are free. A solo mobile provider and a 40-clinician group use the same pricing structure.

How does this compare to per-seat EMRs?

Per-seat charges you monthly for every login, filled or not. Pay-per-Chart charges only for completed AI drafts. Practices with part-time staff, on-call nurses, or variable volume typically pay less.

What's included at no cost?

Unlimited patient records, storage, logins, imaging capture, and access to the healing dashboard. Credits are strictly for AI drafting work.

Can I see a cost estimate before committing?

Yes. Count your monthly wound visits, multiply by the credit price, and compare to your current per-seat invoice. Most practices see the math immediately.

For the pricing philosophy behind these answers, read Charts or Chairs — that is the question.